Rx Medicare

Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Read More…

Related Posts

• Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• USDA Conducting Confirmatory Testing On Possible Detection Of 2009 Pandemic H1N1 Influenza In U.S. Swine
• Meridian Granted Special 510(k) Clearance To Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim To The TRU FLU(R) Test Package Insert
• CSL Biotherapies Announces Start Of U.S. H1N1 Vaccine Clinical Trials
• Sinovac Reports Positive Preliminary Results For Clinical Trials Of H1N1 Vaccine
• US To Start Human Trials Of H1N1 Swine Flu Vaccine In August
• Drugs That Fight 2009 H1N1 Influenza A Swine Flu To Be Screened By SRI International
• 15 Countries Report 615 Swine Flu (influenza A H1N1) Cases Of Infection Among Humans, 2nd May 2009
• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine

Tags: 2009, candidates, clinical, efficacy, h1n1, influenza, niaid, swine, test, trials, vaccine

This entry was posted on Friday, July 24th, 2009 at 1:07 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.